世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界および日本の2019-nCoVアッセイ市場の洞察、2027年までの予測


Global and Japan 2019-nCoV Assay Market Insights, Forecast to 2027

新冠状動脈性肺炎にかかっているかどうかを検出するための薬剤です。 市場分析とインサイト。世界と日本の2019-nCoVアッセイ市場 当レポートでは、世界と日本の2019-nCoVアッセイ市場に焦点を当てています。 ... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2021年11月26日 US$3,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

新冠状動脈性肺炎にかかっているかどうかを検出するための薬剤です。

市場分析とインサイト。世界と日本の2019-nCoVアッセイ市場
当レポートでは、世界と日本の2019-nCoVアッセイ市場に焦点を当てています。
2020年の世界の2019-nCoV Assay市場規模はXX百万米ドルで、2021-2027年の間にXX%のCAGRで、2027年末までにXX百万米ドルに達すると予想されています。日本では、2019-nCoVアッセイの市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルまで、予測期間中にXX%のCAGRで成長すると予測されています。

2019-nCoVアッセイの世界規模の範囲と市場規模
2019-nCoV Assay市場は、地域(国)別、プレイヤー別、タイプ別、アプリケーション別に分類されています。2019-nCoV Assayの世界市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント分析では、2016年から2027年までの地域(国)別、タイプ別、アプリケーション別の売上高と予測に焦点を当てています。
日本市場では、2016年から2027年の期間で、2019-nCoVアッセイの市場規模を、プレイヤー別、タイプ別、アプリケーション別に取り上げています。主要プレイヤーには、日本で重要な役割を果たしているグローバルプレイヤーとローカルプレイヤーが含まれています。

タイプ別セグメント
核酸検出キット
抗体検出キット

アプリケーション別
指定病院
診断センター
科学研究
ポートオブエントリー
個人
その他

地域別
北アメリカ
米国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
UAE

会社別
上海ZJバイオテック
上海Geneodx Biotech社
イノビータ
Genomics Biotech (Wuhan)
Zhongshan Daan Gene
サナウレ
上海Bio-Germ
広州元宝生物技術有限公司
成都Boaojingバイオテック
北京XABT
バイオサイエンス(重慶)バイオテック
Maccuraバイオテック
厦門InnoDx
広東Hecin-Scientific
武漢Easydiagnosis Biomedicine
Seegene
PharmACT
エバリーウェル
Biopanda
Mylab Discovery


ページTOPに戻る


目次

1 Study Coverage
1.1 2019-nCoV Assay Product Introduction
1.2 Market by Type
1.2.1 Global 2019-nCoV Assay Market Size Growth Rate by Type
1.2.2 Nucleic Acid Detection Kit
1.2.3 Antibody Detection Kit
1.3 Market by Application
1.3.1 Global 2019-nCoV Assay Market Size Growth Rate by Application
1.3.2 Designated Hospital
1.3.3 Diagnostic Center
1.3.4 Scientific Research
1.3.5 Port of Entry
1.3.6 Individual
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global 2019-nCoV Assay Market Size, Estimates and Forecasts
2.1.1 Global 2019-nCoV Assay Revenue 2016-2027
2.1.2 Global 2019-nCoV Assay Sales 2016-2027
2.2 Global 2019-nCoV Assay, Market Size by Region: 2016 VS 2021 VS 2027
2.3 2019-nCoV Assay Historical Market Size by Region (2016-2021)
2.3.1 Global 2019-nCoV Assay Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global 2019-nCoV Assay Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 2019-nCoV Assay Market Estimates and Projections by Region (2022-2027)
2.4.1 Global 2019-nCoV Assay Sales Forecast by Region (2022-2027)
2.4.2 Global 2019-nCoV Assay Revenue Forecast by Region (2022-2027)

3 Global 2019-nCoV Assay Competitor Landscape by Players
3.1 Global Top 2019-nCoV Assay Manufacturers by Sales
3.1.1 Global 2019-nCoV Assay Sales by Manufacturer (2016-2021)
3.1.2 Global 2019-nCoV Assay Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top 2019-nCoV Assay Manufacturers by Revenue
3.2.1 Key 2019-nCoV Assay Manufacturers Covered: Ranking by Revenue
3.2.2 Global 2019-nCoV Assay Revenue by Manufacturers (2016-2021)
3.2.3 Global 2019-nCoV Assay Revenue Share by Manufacturers (2016-2021)
3.2.4 Global 2019-nCoV Assay Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by 2019-nCoV Assay Revenue in 2020
3.2.6 Global 2019-nCoV Assay Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global 2019-nCoV Assay Price by Manufacturers
3.4 Global 2019-nCoV Assay Manufacturing Base Distribution, Product Types
3.4.1 2019-nCoV Assay Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers 2019-nCoV Assay Product Type
3.4.3 Date of International Manufacturers Enter into 2019-nCoV Assay Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global 2019-nCoV Assay Market Size by Type (2016-2021)
4.1.1 Global 2019-nCoV Assay Sales by Type (2016-2021)
4.1.2 Global 2019-nCoV Assay Revenue by Type (2016-2021)
4.1.3 2019-nCoV Assay Average Selling Price (ASP) by Type (2016-2021)
4.2 Global 2019-nCoV Assay Market Size Forecast by Type (2022-2027)
4.2.1 Global 2019-nCoV Assay Sales Forecast by Type (2022-2027)
4.2.2 Global 2019-nCoV Assay Revenue Forecast by Type (2022-2027)
4.2.3 2019-nCoV Assay Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global 2019-nCoV Assay Market Size by Application (2016-2021)
5.1.1 Global 2019-nCoV Assay Sales by Application (2016-2021)
5.1.2 Global 2019-nCoV Assay Revenue by Application (2016-2021)
5.1.3 2019-nCoV Assay Price by Application (2016-2021)
5.2 2019-nCoV Assay Market Size Forecast by Application (2022-2027)
5.2.1 Global 2019-nCoV Assay Sales Forecast by Application (2022-2027)
5.2.2 Global 2019-nCoV Assay Revenue Forecast by Application (2022-2027)
5.2.3 Global 2019-nCoV Assay Price Forecast by Application (2022-2027)

6 Japan by Players, Type and Application
6.1 Japan 2019-nCoV Assay Market Size YoY Growth 2016-2027
6.1.1 Japan 2019-nCoV Assay Sales YoY Growth 2016-2027
6.1.2 Japan 2019-nCoV Assay Revenue YoY Growth 2016-2027
6.1.3 Japan 2019-nCoV Assay Market Share in Global Market 2016-2027
6.2 Japan 2019-nCoV Assay Market Size by Players (International and Local Players)
6.2.1 Japan Top 2019-nCoV Assay Players by Sales (2016-2021)
6.2.2 Japan Top 2019-nCoV Assay Players by Revenue (2016-2021)
6.3 Japan 2019-nCoV Assay Historic Market Review by Type (2016-2021)
6.3.1 Japan 2019-nCoV Assay Sales Market Share by Type (2016-2021)
6.3.2 Japan 2019-nCoV Assay Revenue Market Share by Type (2016-2021)
6.3.3 Japan 2019-nCoV Assay Price by Type (2016-2021)
6.4 Japan 2019-nCoV Assay Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan 2019-nCoV Assay Sales Forecast by Type (2022-2027)
6.4.2 Japan 2019-nCoV Assay Revenue Forecast by Type (2022-2027)
6.4.3 Japan 2019-nCoV Assay Price Forecast by Type (2022-2027)
6.5 Japan 2019-nCoV Assay Historic Market Review by Application (2016-2021)
6.5.1 Japan 2019-nCoV Assay Sales Market Share by Application (2016-2021)
6.5.2 Japan 2019-nCoV Assay Revenue Market Share by Application (2016-2021)
6.5.3 Japan 2019-nCoV Assay Price by Application (2016-2021)
6.6 Japan 2019-nCoV Assay Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan 2019-nCoV Assay Sales Forecast by Application (2022-2027)
6.6.2 Japan 2019-nCoV Assay Revenue Forecast by Application (2022-2027)
6.6.3 Japan 2019-nCoV Assay Price Forecast by Application (2022-2027)

7 North America
7.1 North America 2019-nCoV Assay Market Size YoY Growth 2016-2027
7.2 North America 2019-nCoV Assay Market Facts & Figures by Country
7.2.1 North America 2019-nCoV Assay Sales by Country (2016-2021)
7.2.2 North America 2019-nCoV Assay Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific 2019-nCoV Assay Market Size YoY Growth 2016-2027
8.2 Asia Pacific 2019-nCoV Assay Market Facts & Figures by Region
8.2.1 Asia Pacific 2019-nCoV Assay Sales by Region (2016-2021)
8.2.2 Asia Pacific 2019-nCoV Assay Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe 2019-nCoV Assay Market Size YoY Growth 2016-2027
9.2 Europe 2019-nCoV Assay Market Facts & Figures by Country
9.2.1 Europe 2019-nCoV Assay Sales by Country (2016-2021)
9.2.2 Europe 2019-nCoV Assay Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America 2019-nCoV Assay Market Size YoY Growth 2016-2027
10.2 Latin America 2019-nCoV Assay Market Facts & Figures by Country
10.2.1 Latin America 2019-nCoV Assay Sales by Country (2016-2021)
10.2.2 Latin America 2019-nCoV Assay Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa 2019-nCoV Assay Market Size YoY Growth 2016-2027
11.2 Middle East and Africa 2019-nCoV Assay Market Facts & Figures by Country
11.2.1 Middle East and Africa 2019-nCoV Assay Sales by Country (2016-2021)
11.2.2 Middle East and Africa 2019-nCoV Assay Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 Shanghai ZJ Bio-Tech
12.1.1 Shanghai ZJ Bio-Tech Corporation Information
12.1.2 Shanghai ZJ Bio-Tech Description and Business Overview
12.1.3 Shanghai ZJ Bio-Tech 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Shanghai ZJ Bio-Tech 2019-nCoV Assay Products Offered
12.1.5 Shanghai ZJ Bio-Tech Recent Development
12.2 Shanghai Geneodx Biotech
12.2.1 Shanghai Geneodx Biotech Corporation Information
12.2.2 Shanghai Geneodx Biotech Description and Business Overview
12.2.3 Shanghai Geneodx Biotech 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Shanghai Geneodx Biotech 2019-nCoV Assay Products Offered
12.2.5 Shanghai Geneodx Biotech Recent Development
12.3 INNOVITA
12.3.1 INNOVITA Corporation Information
12.3.2 INNOVITA Description and Business Overview
12.3.3 INNOVITA 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.3.4 INNOVITA 2019-nCoV Assay Products Offered
12.3.5 INNOVITA Recent Development
12.4 Genomics Biotech (Wuhan)
12.4.1 Genomics Biotech (Wuhan) Corporation Information
12.4.2 Genomics Biotech (Wuhan) Description and Business Overview
12.4.3 Genomics Biotech (Wuhan) 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Genomics Biotech (Wuhan) 2019-nCoV Assay Products Offered
12.4.5 Genomics Biotech (Wuhan) Recent Development
12.5 Zhongshan Daan Gene
12.5.1 Zhongshan Daan Gene Corporation Information
12.5.2 Zhongshan Daan Gene Description and Business Overview
12.5.3 Zhongshan Daan Gene 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Zhongshan Daan Gene 2019-nCoV Assay Products Offered
12.5.5 Zhongshan Daan Gene Recent Development
12.6 Sanaure
12.6.1 Sanaure Corporation Information
12.6.2 Sanaure Description and Business Overview
12.6.3 Sanaure 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Sanaure 2019-nCoV Assay Products Offered
12.6.5 Sanaure Recent Development
12.7 Shanghai Bio-Germ
12.7.1 Shanghai Bio-Germ Corporation Information
12.7.2 Shanghai Bio-Germ Description and Business Overview
12.7.3 Shanghai Bio-Germ 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Shanghai Bio-Germ 2019-nCoV Assay Products Offered
12.7.5 Shanghai Bio-Germ Recent Development
12.8 Guangzhou Wonfo Bio-Tech
12.8.1 Guangzhou Wonfo Bio-Tech Corporation Information
12.8.2 Guangzhou Wonfo Bio-Tech Description and Business Overview
12.8.3 Guangzhou Wonfo Bio-Tech 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Guangzhou Wonfo Bio-Tech 2019-nCoV Assay Products Offered
12.8.5 Guangzhou Wonfo Bio-Tech Recent Development
12.9 Chengdu Boaojing Bio-Tech
12.9.1 Chengdu Boaojing Bio-Tech Corporation Information
12.9.2 Chengdu Boaojing Bio-Tech Description and Business Overview
12.9.3 Chengdu Boaojing Bio-Tech 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Chengdu Boaojing Bio-Tech 2019-nCoV Assay Products Offered
12.9.5 Chengdu Boaojing Bio-Tech Recent Development
12.10 Beijing XABT
12.10.1 Beijing XABT Corporation Information
12.10.2 Beijing XABT Description and Business Overview
12.10.3 Beijing XABT 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Beijing XABT 2019-nCoV Assay Products Offered
12.10.5 Beijing XABT Recent Development
12.11 Shanghai ZJ Bio-Tech
12.11.1 Shanghai ZJ Bio-Tech Corporation Information
12.11.2 Shanghai ZJ Bio-Tech Description and Business Overview
12.11.3 Shanghai ZJ Bio-Tech 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Shanghai ZJ Bio-Tech 2019-nCoV Assay Products Offered
12.11.5 Shanghai ZJ Bio-Tech Recent Development
12.12 Maccura Bio-Tech
12.12.1 Maccura Bio-Tech Corporation Information
12.12.2 Maccura Bio-Tech Description and Business Overview
12.12.3 Maccura Bio-Tech 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Maccura Bio-Tech Products Offered
12.12.5 Maccura Bio-Tech Recent Development
12.13 Xiamen InnoDx
12.13.1 Xiamen InnoDx Corporation Information
12.13.2 Xiamen InnoDx Description and Business Overview
12.13.3 Xiamen InnoDx 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Xiamen InnoDx Products Offered
12.13.5 Xiamen InnoDx Recent Development
12.14 Guangdong Hecin-Scientific
12.14.1 Guangdong Hecin-Scientific Corporation Information
12.14.2 Guangdong Hecin-Scientific Description and Business Overview
12.14.3 Guangdong Hecin-Scientific 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Guangdong Hecin-Scientific Products Offered
12.14.5 Guangdong Hecin-Scientific Recent Development
12.15 Wuhan Easydiagnosis Biomedicine
12.15.1 Wuhan Easydiagnosis Biomedicine Corporation Information
12.15.2 Wuhan Easydiagnosis Biomedicine Description and Business Overview
12.15.3 Wuhan Easydiagnosis Biomedicine 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Wuhan Easydiagnosis Biomedicine Products Offered
12.15.5 Wuhan Easydiagnosis Biomedicine Recent Development
12.16 Seegene
12.16.1 Seegene Corporation Information
12.16.2 Seegene Description and Business Overview
12.16.3 Seegene 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Seegene Products Offered
12.16.5 Seegene Recent Development
12.17 PharmACT
12.17.1 PharmACT Corporation Information
12.17.2 PharmACT Description and Business Overview
12.17.3 PharmACT 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.17.4 PharmACT Products Offered
12.17.5 PharmACT Recent Development
12.18 Everlywell
12.18.1 Everlywell Corporation Information
12.18.2 Everlywell Description and Business Overview
12.18.3 Everlywell 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Everlywell Products Offered
12.18.5 Everlywell Recent Development
12.19 Biopanda
12.19.1 Biopanda Corporation Information
12.19.2 Biopanda Description and Business Overview
12.19.3 Biopanda 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Biopanda Products Offered
12.19.5 Biopanda Recent Development
12.20 Mylab Discovery
12.20.1 Mylab Discovery Corporation Information
12.20.2 Mylab Discovery Description and Business Overview
12.20.3 Mylab Discovery 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Mylab Discovery Products Offered
12.20.5 Mylab Discovery Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 2019-nCoV Assay Industry Trends
13.2 2019-nCoV Assay Market Drivers
13.3 2019-nCoV Assay Market Challenges
13.4 2019-nCoV Assay Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 2019-nCoV Assay Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

 

ページTOPに戻る


 

Summary

It is an agent used to detect if you have new coronary pneumonia.

Market Analysis and Insights: Global and Japan 2019-nCoV Assay Market
This report focuses on global and Japan 2019-nCoV Assay market.
In 2020, the global 2019-nCoV Assay market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In Japan the 2019-nCoV Assay market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global 2019-nCoV Assay Scope and Market Size
2019-nCoV Assay market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global 2019-nCoV Assay market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For Japan market, this report focuses on the 2019-nCoV Assay market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type
Nucleic Acid Detection Kit
Antibody Detection Kit

Segment by Application
Designated Hospital
Diagnostic Center
Scientific Research
Port of Entry
Individual
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Shanghai ZJ Bio-Tech
Shanghai Geneodx Biotech
INNOVITA
Genomics Biotech (Wuhan)
Zhongshan Daan Gene
Sanaure
Shanghai Bio-Germ
Guangzhou Wonfo Bio-Tech
Chengdu Boaojing Bio-Tech
Beijing XABT
Bioscience(Chongqing) Bio-Tech
Maccura Bio-Tech
Xiamen InnoDx
Guangdong Hecin-Scientific
Wuhan Easydiagnosis Biomedicine
Seegene
PharmACT
Everlywell
Biopanda
Mylab Discovery



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 2019-nCoV Assay Product Introduction
1.2 Market by Type
1.2.1 Global 2019-nCoV Assay Market Size Growth Rate by Type
1.2.2 Nucleic Acid Detection Kit
1.2.3 Antibody Detection Kit
1.3 Market by Application
1.3.1 Global 2019-nCoV Assay Market Size Growth Rate by Application
1.3.2 Designated Hospital
1.3.3 Diagnostic Center
1.3.4 Scientific Research
1.3.5 Port of Entry
1.3.6 Individual
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global 2019-nCoV Assay Market Size, Estimates and Forecasts
2.1.1 Global 2019-nCoV Assay Revenue 2016-2027
2.1.2 Global 2019-nCoV Assay Sales 2016-2027
2.2 Global 2019-nCoV Assay, Market Size by Region: 2016 VS 2021 VS 2027
2.3 2019-nCoV Assay Historical Market Size by Region (2016-2021)
2.3.1 Global 2019-nCoV Assay Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global 2019-nCoV Assay Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 2019-nCoV Assay Market Estimates and Projections by Region (2022-2027)
2.4.1 Global 2019-nCoV Assay Sales Forecast by Region (2022-2027)
2.4.2 Global 2019-nCoV Assay Revenue Forecast by Region (2022-2027)

3 Global 2019-nCoV Assay Competitor Landscape by Players
3.1 Global Top 2019-nCoV Assay Manufacturers by Sales
3.1.1 Global 2019-nCoV Assay Sales by Manufacturer (2016-2021)
3.1.2 Global 2019-nCoV Assay Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top 2019-nCoV Assay Manufacturers by Revenue
3.2.1 Key 2019-nCoV Assay Manufacturers Covered: Ranking by Revenue
3.2.2 Global 2019-nCoV Assay Revenue by Manufacturers (2016-2021)
3.2.3 Global 2019-nCoV Assay Revenue Share by Manufacturers (2016-2021)
3.2.4 Global 2019-nCoV Assay Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by 2019-nCoV Assay Revenue in 2020
3.2.6 Global 2019-nCoV Assay Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global 2019-nCoV Assay Price by Manufacturers
3.4 Global 2019-nCoV Assay Manufacturing Base Distribution, Product Types
3.4.1 2019-nCoV Assay Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers 2019-nCoV Assay Product Type
3.4.3 Date of International Manufacturers Enter into 2019-nCoV Assay Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global 2019-nCoV Assay Market Size by Type (2016-2021)
4.1.1 Global 2019-nCoV Assay Sales by Type (2016-2021)
4.1.2 Global 2019-nCoV Assay Revenue by Type (2016-2021)
4.1.3 2019-nCoV Assay Average Selling Price (ASP) by Type (2016-2021)
4.2 Global 2019-nCoV Assay Market Size Forecast by Type (2022-2027)
4.2.1 Global 2019-nCoV Assay Sales Forecast by Type (2022-2027)
4.2.2 Global 2019-nCoV Assay Revenue Forecast by Type (2022-2027)
4.2.3 2019-nCoV Assay Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global 2019-nCoV Assay Market Size by Application (2016-2021)
5.1.1 Global 2019-nCoV Assay Sales by Application (2016-2021)
5.1.2 Global 2019-nCoV Assay Revenue by Application (2016-2021)
5.1.3 2019-nCoV Assay Price by Application (2016-2021)
5.2 2019-nCoV Assay Market Size Forecast by Application (2022-2027)
5.2.1 Global 2019-nCoV Assay Sales Forecast by Application (2022-2027)
5.2.2 Global 2019-nCoV Assay Revenue Forecast by Application (2022-2027)
5.2.3 Global 2019-nCoV Assay Price Forecast by Application (2022-2027)

6 Japan by Players, Type and Application
6.1 Japan 2019-nCoV Assay Market Size YoY Growth 2016-2027
6.1.1 Japan 2019-nCoV Assay Sales YoY Growth 2016-2027
6.1.2 Japan 2019-nCoV Assay Revenue YoY Growth 2016-2027
6.1.3 Japan 2019-nCoV Assay Market Share in Global Market 2016-2027
6.2 Japan 2019-nCoV Assay Market Size by Players (International and Local Players)
6.2.1 Japan Top 2019-nCoV Assay Players by Sales (2016-2021)
6.2.2 Japan Top 2019-nCoV Assay Players by Revenue (2016-2021)
6.3 Japan 2019-nCoV Assay Historic Market Review by Type (2016-2021)
6.3.1 Japan 2019-nCoV Assay Sales Market Share by Type (2016-2021)
6.3.2 Japan 2019-nCoV Assay Revenue Market Share by Type (2016-2021)
6.3.3 Japan 2019-nCoV Assay Price by Type (2016-2021)
6.4 Japan 2019-nCoV Assay Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan 2019-nCoV Assay Sales Forecast by Type (2022-2027)
6.4.2 Japan 2019-nCoV Assay Revenue Forecast by Type (2022-2027)
6.4.3 Japan 2019-nCoV Assay Price Forecast by Type (2022-2027)
6.5 Japan 2019-nCoV Assay Historic Market Review by Application (2016-2021)
6.5.1 Japan 2019-nCoV Assay Sales Market Share by Application (2016-2021)
6.5.2 Japan 2019-nCoV Assay Revenue Market Share by Application (2016-2021)
6.5.3 Japan 2019-nCoV Assay Price by Application (2016-2021)
6.6 Japan 2019-nCoV Assay Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan 2019-nCoV Assay Sales Forecast by Application (2022-2027)
6.6.2 Japan 2019-nCoV Assay Revenue Forecast by Application (2022-2027)
6.6.3 Japan 2019-nCoV Assay Price Forecast by Application (2022-2027)

7 North America
7.1 North America 2019-nCoV Assay Market Size YoY Growth 2016-2027
7.2 North America 2019-nCoV Assay Market Facts & Figures by Country
7.2.1 North America 2019-nCoV Assay Sales by Country (2016-2021)
7.2.2 North America 2019-nCoV Assay Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific 2019-nCoV Assay Market Size YoY Growth 2016-2027
8.2 Asia Pacific 2019-nCoV Assay Market Facts & Figures by Region
8.2.1 Asia Pacific 2019-nCoV Assay Sales by Region (2016-2021)
8.2.2 Asia Pacific 2019-nCoV Assay Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe 2019-nCoV Assay Market Size YoY Growth 2016-2027
9.2 Europe 2019-nCoV Assay Market Facts & Figures by Country
9.2.1 Europe 2019-nCoV Assay Sales by Country (2016-2021)
9.2.2 Europe 2019-nCoV Assay Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America 2019-nCoV Assay Market Size YoY Growth 2016-2027
10.2 Latin America 2019-nCoV Assay Market Facts & Figures by Country
10.2.1 Latin America 2019-nCoV Assay Sales by Country (2016-2021)
10.2.2 Latin America 2019-nCoV Assay Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa 2019-nCoV Assay Market Size YoY Growth 2016-2027
11.2 Middle East and Africa 2019-nCoV Assay Market Facts & Figures by Country
11.2.1 Middle East and Africa 2019-nCoV Assay Sales by Country (2016-2021)
11.2.2 Middle East and Africa 2019-nCoV Assay Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 Shanghai ZJ Bio-Tech
12.1.1 Shanghai ZJ Bio-Tech Corporation Information
12.1.2 Shanghai ZJ Bio-Tech Description and Business Overview
12.1.3 Shanghai ZJ Bio-Tech 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Shanghai ZJ Bio-Tech 2019-nCoV Assay Products Offered
12.1.5 Shanghai ZJ Bio-Tech Recent Development
12.2 Shanghai Geneodx Biotech
12.2.1 Shanghai Geneodx Biotech Corporation Information
12.2.2 Shanghai Geneodx Biotech Description and Business Overview
12.2.3 Shanghai Geneodx Biotech 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Shanghai Geneodx Biotech 2019-nCoV Assay Products Offered
12.2.5 Shanghai Geneodx Biotech Recent Development
12.3 INNOVITA
12.3.1 INNOVITA Corporation Information
12.3.2 INNOVITA Description and Business Overview
12.3.3 INNOVITA 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.3.4 INNOVITA 2019-nCoV Assay Products Offered
12.3.5 INNOVITA Recent Development
12.4 Genomics Biotech (Wuhan)
12.4.1 Genomics Biotech (Wuhan) Corporation Information
12.4.2 Genomics Biotech (Wuhan) Description and Business Overview
12.4.3 Genomics Biotech (Wuhan) 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Genomics Biotech (Wuhan) 2019-nCoV Assay Products Offered
12.4.5 Genomics Biotech (Wuhan) Recent Development
12.5 Zhongshan Daan Gene
12.5.1 Zhongshan Daan Gene Corporation Information
12.5.2 Zhongshan Daan Gene Description and Business Overview
12.5.3 Zhongshan Daan Gene 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Zhongshan Daan Gene 2019-nCoV Assay Products Offered
12.5.5 Zhongshan Daan Gene Recent Development
12.6 Sanaure
12.6.1 Sanaure Corporation Information
12.6.2 Sanaure Description and Business Overview
12.6.3 Sanaure 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Sanaure 2019-nCoV Assay Products Offered
12.6.5 Sanaure Recent Development
12.7 Shanghai Bio-Germ
12.7.1 Shanghai Bio-Germ Corporation Information
12.7.2 Shanghai Bio-Germ Description and Business Overview
12.7.3 Shanghai Bio-Germ 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Shanghai Bio-Germ 2019-nCoV Assay Products Offered
12.7.5 Shanghai Bio-Germ Recent Development
12.8 Guangzhou Wonfo Bio-Tech
12.8.1 Guangzhou Wonfo Bio-Tech Corporation Information
12.8.2 Guangzhou Wonfo Bio-Tech Description and Business Overview
12.8.3 Guangzhou Wonfo Bio-Tech 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Guangzhou Wonfo Bio-Tech 2019-nCoV Assay Products Offered
12.8.5 Guangzhou Wonfo Bio-Tech Recent Development
12.9 Chengdu Boaojing Bio-Tech
12.9.1 Chengdu Boaojing Bio-Tech Corporation Information
12.9.2 Chengdu Boaojing Bio-Tech Description and Business Overview
12.9.3 Chengdu Boaojing Bio-Tech 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Chengdu Boaojing Bio-Tech 2019-nCoV Assay Products Offered
12.9.5 Chengdu Boaojing Bio-Tech Recent Development
12.10 Beijing XABT
12.10.1 Beijing XABT Corporation Information
12.10.2 Beijing XABT Description and Business Overview
12.10.3 Beijing XABT 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Beijing XABT 2019-nCoV Assay Products Offered
12.10.5 Beijing XABT Recent Development
12.11 Shanghai ZJ Bio-Tech
12.11.1 Shanghai ZJ Bio-Tech Corporation Information
12.11.2 Shanghai ZJ Bio-Tech Description and Business Overview
12.11.3 Shanghai ZJ Bio-Tech 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Shanghai ZJ Bio-Tech 2019-nCoV Assay Products Offered
12.11.5 Shanghai ZJ Bio-Tech Recent Development
12.12 Maccura Bio-Tech
12.12.1 Maccura Bio-Tech Corporation Information
12.12.2 Maccura Bio-Tech Description and Business Overview
12.12.3 Maccura Bio-Tech 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Maccura Bio-Tech Products Offered
12.12.5 Maccura Bio-Tech Recent Development
12.13 Xiamen InnoDx
12.13.1 Xiamen InnoDx Corporation Information
12.13.2 Xiamen InnoDx Description and Business Overview
12.13.3 Xiamen InnoDx 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Xiamen InnoDx Products Offered
12.13.5 Xiamen InnoDx Recent Development
12.14 Guangdong Hecin-Scientific
12.14.1 Guangdong Hecin-Scientific Corporation Information
12.14.2 Guangdong Hecin-Scientific Description and Business Overview
12.14.3 Guangdong Hecin-Scientific 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Guangdong Hecin-Scientific Products Offered
12.14.5 Guangdong Hecin-Scientific Recent Development
12.15 Wuhan Easydiagnosis Biomedicine
12.15.1 Wuhan Easydiagnosis Biomedicine Corporation Information
12.15.2 Wuhan Easydiagnosis Biomedicine Description and Business Overview
12.15.3 Wuhan Easydiagnosis Biomedicine 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Wuhan Easydiagnosis Biomedicine Products Offered
12.15.5 Wuhan Easydiagnosis Biomedicine Recent Development
12.16 Seegene
12.16.1 Seegene Corporation Information
12.16.2 Seegene Description and Business Overview
12.16.3 Seegene 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Seegene Products Offered
12.16.5 Seegene Recent Development
12.17 PharmACT
12.17.1 PharmACT Corporation Information
12.17.2 PharmACT Description and Business Overview
12.17.3 PharmACT 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.17.4 PharmACT Products Offered
12.17.5 PharmACT Recent Development
12.18 Everlywell
12.18.1 Everlywell Corporation Information
12.18.2 Everlywell Description and Business Overview
12.18.3 Everlywell 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Everlywell Products Offered
12.18.5 Everlywell Recent Development
12.19 Biopanda
12.19.1 Biopanda Corporation Information
12.19.2 Biopanda Description and Business Overview
12.19.3 Biopanda 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Biopanda Products Offered
12.19.5 Biopanda Recent Development
12.20 Mylab Discovery
12.20.1 Mylab Discovery Corporation Information
12.20.2 Mylab Discovery Description and Business Overview
12.20.3 Mylab Discovery 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Mylab Discovery Products Offered
12.20.5 Mylab Discovery Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 2019-nCoV Assay Industry Trends
13.2 2019-nCoV Assay Market Drivers
13.3 2019-nCoV Assay Market Challenges
13.4 2019-nCoV Assay Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 2019-nCoV Assay Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/14 10:27

156.77 円

166.04 円

201.95 円

ページTOPに戻る